to prevent just one cardiovascular event. 5 Thus, using a single blood pressure threshold to identify the need for antihypertensive therapy may not be the optimal approach. Instead, the total or global risk for cardiovascular events should be an additional basis upon which to determine the potential value of and, therefore, the need for pharmacological intervention. The result may well be the initiation of therapy in persons not meeting the conventional definition for hypertension. 6 A more recent trial evaluated the addition of perindopril and indapamide (compared with that of a placebo) to the medical regimen of patients regardless of their blood pressure, but with diabetes and clinical cardiovascular disease or other cardiovascular risk factors. 7 Mean blood pressure at enrollment was 145/81 mm Hg, and during the trial, active treatment was associated with a decline in blood pressure of 5.6/2.2 mm Hg when compared with the placebo treatment. Although the confidence interval was wide, active treatment was associated with a decreased risk for the composite endpoint of micro-or macrovascular disease (hazard ratio, 0.91; 95% CI, 0.83-1.00). On the average, 77 people need to be treated for 4.3 years (331 person years of treatment) to prevent one micro-or macro-vascular event. Future US guidelines may be improved by taking the cardiovascular risk as well as BP level into account when designing algorithms to guide treatment decisions. 
White-coat Effect: Unraveling Its Mechanisms
Gbenga Ogedegbe 1 W hite-coat effect (WCE), often defined as the difference between office blood pressure (office BP) and average daytime ambulatory BP, is a relatively common phenomenon noted in most hypertensive, and, to a lesser degree, in normotensive subjects. 1 It is important to note the difference between white coat hypertension and WCE, with the former reflecting a measure of BP level, and the latter being a measure of BP change. 2 While the prognostic relevance of WCE remains controversial, factors influencing WCE have been an area of investigation in recent years and may actually shed light on its clinical significance. Potential predictors of WCE identified in previous studies include age, office BP, smoking, family history of cardiovascular disease, and duration as well as treatment of hypertension. 2, 3 However, its magnitude, as well as the relative weights of these factors in different subcategories of hypertension among untreated patients, has not been studied.
This issue of the Journal presents an article by Manios et al. that assessed the determinants of WCE among 2,004 untreated and suspected hypertensives, who received care in a hospitalbased practice. The authors teased out the relative weights of each variable through their beta coefficients in a regression model that explained 39-50% of the variance. Not surprisingly, the authors' findings confirmed what has been previously reported: that office BP, female gender, daytime BP variability, age, and smoking status were independent predictors of systolic and diastolic WCE in decreasing order of magnitude. A major strength of this study is the partitioning of the WCE according to the hypertension diagnostic subcategory. The mean systolic and diastolic WCE were 9/12 mm Hg (±s.d. 16/12), with larger WCE noted in sustained hypertensives compared to white coat hypertensives and normotensives (15/11, 13/9, and 11/9 mm Hg), respectively.
Two important limitations of this study should be noted. First is the significant selection bias given that the patient cohort was drawn from a tertiary hypertension center. These patients tend to be sicker than the general practice population. Second, and more importantly, most of these patients may have been given a diagnosis of hypertension (labeling effect) and as such may have a higher anxiety level or increased conditioned response to subsequent BP measurement. 4 We recently found a positive relationship between perception of being hypertensive, anxiety levels, and WCE in a cohort of normotensive and mildly hypertensive patients. 5 Thus, teasing out the effect of labeling should be a component of studies geared at determining the causes of WCE. Because of the strong relationship that exists between WCE and anxiety during BP assessment, an interesting research question related to the causes of WCE will be to assess the interaction between the determinants of WCE (noted in this study) and anxiety levels during BP measurement. It is plausible that women generally have higher anxiety levels than men, or they may exhibit a higher alertness or conditioned response to repeated BP measurement than men. The same may be true for older age, smoking, and BP variability. These are certainly areas for future research aimed at unraveling the mechanisms of WCE.
